Abstract
Spontaneous vertebral artery dissecting aneurysm has been increasingly attributed as a major cause of focal neurological deficits due to vertebrobasilar artery ischemia or subarachnoid hemorrhage (SAH). Although the development of spontaneous vertebral artery dissecting aneurysm (VADA) is rare, de novo VADA after treatment of contralateral vertebral artery (VA) is more less frequently observed. There are only a few reports related to de novo VADA after treatment of the contralateral VA in the medical literature. The mechanisms responsible for de novo dissection after treatment of unilateral VADA are still not clearly understood. In this manuscript, we report an unusual case of a patient with a de novo VADA after placement of a pipeline embolization device (PED) stent on the contralateral VA along with a thorough review of the literature. A 42-years old male patient was referred to the hospital with sudden onset of dizziness, nausea, and vomiting. Initial digital subtraction angiography (DSA) images demonstrated a VADA in the fourth segment of the left VA without the involvement of the posterior inferior cerebellar artery (PICA). There were no significant abnormalities found in the right vertebral artery. He underwent an endovascular pipeline embolization to treat the dissecting aneurysm (DA). Surprisingly, follow-up DSA imaging 14 months after the initial treatment showed a segmental dilatation and narrowing of the right VA, which suggested a de novo VADA on the right side that had occurred postoperatively. This was followed by a tent-assisted coil embolization therapy for occluding this de novo VADA. This patient showed an uneventful postoperative course with no neurological abnormalities. In addition to hemodynamic stress changes, the unique clinicopathological features of dissecting aneurysms may contribute significantly to the pathogenesis of de novo VA dissection. Given that VA in VADA patients may be vulnerable on both sides, it is important to consider the risk of de novo dissection after initial aneurysm treatment. The bilateral vertebral artery has to be carefully observed when treating any VADA patient to prevent any complications.
Highlights
With a significant improvement in the understanding of the disease entity and angiographic appearance, the vertebral artery dissecting aneurysm (VADA) is considered rare, but has been increasingly reported as a fairly common cause of subarachnoid hemorrhage (SAH) or brain stem ischemia [1]
The development of spontaneous vertebral artery (VA) dissecting aneurysm is of rare occurrence, and de novo VADA after treatment of contralateral VA has been even less commonly observed
We report an unusual case of a patient with a de novo VADA after placement of a pipeline embolization device (PED) stent on the contralateral VA followed by an exhaustive literature review
Summary
With a significant improvement in the understanding of the disease entity and angiographic appearance, the vertebral artery dissecting aneurysm (VADA) is considered rare, but has been increasingly reported as a fairly common cause of subarachnoid hemorrhage (SAH) or brain stem ischemia [1]. Mechanisms underlying de novo dissection after treatment of unilateral VADA have not been completely deciphered In this manuscript, we report an unusual case of a patient with a de novo VADA after placement of a PED stent on the contralateral VA followed by an exhaustive literature review. No intraoperative complications were encountered, and the right VA was preserved He was discharged home 1 week after the operation and prescribed dual antiplatelet therapy (aspirin 100 mg/day and clopidogrel l00 mg/ day) for 6 months. Follow-up imaging 14 months postoperatively showed a segmental dilatation and narrowing of the right VA (Figure 2B), which suggested the formation of a de novo VADA. A 20 months angiography follow-up revealed complete occlusion of the aneurysm (Figure 2D)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.